Extract to table
Pull the structured facts out of a document: parties, dates, amounts, obligations.
Extract to table / stockholder-representative-agreement.docx
stockholder-representative-agreement.docx
Parties
Penterra Pharmaceuticals Corp
Whitfield Graves LLP
Harkness LLP
Dates
November 27, 2023
December 1, 2023
December 31, 2026
June 30, 2027
Amounts
$925,000,000
$0.001
$125,000,000
$1,050,000,000
$46,250,000
$27,750,000
$1,500,000
$693,750,000
$231,250,000
$39.17
Obligations
1 Defined Terms As used in this Agreement, the following terms shall have the meanings set forth below: "Agreement" has the meaning set forth in the Preamble
2 Interpretation and Cross-References (a) Capitalized terms used but not otherwise defined herein shall have the meanings ascribed to such terms in the Merger Agreement
In the event of any ambiguity or question of intent or interpretation arising under this Agreement, this Agreement shall be construed as if drafted jointly by the Parties, and no presumption or burden of proof shall arise favoring or disfavoring any Party by virtue of the authorship of any of the provisions hereof
Such appointment shall not be affected by the death, incapacity, bankruptcy, dissolution, or liquidation of any Former Stockholder
No Former Stockholder shall have any right to revoke, modify, or terminate the Representative's appointment hereunder, except through the removal process set forth in Section 8
(b) Notwithstanding anything to the contrary contained herein, the Representative shall have no obligation to take any action or perform any duty except as expressly set forth in this Agreement